Viewing data from:

FLUPHENAZINE DECANOATE

ANDA

FLUPHENAZINE DECANOATE | A207739 | EUGIA PHARMA SPECIALITIES LTD

1 strength0 unique patents0 unique exclusivities

Medicare Part B Spending

CMS physician-administered drug spending for Fluphenazine Decanoate (2023)

Total Spending

$21K

Total Claims

1,522

Beneficiaries

254

ASP Price

—

HCPCS: J2680 — Injection, fluphenazine decanoate, up to 25 mg

Source: CMS Medicare Part B Spending by Drug (2023). Shows physician-administered drug costs.

API Supply Chain4 active DMFs6 inactive

4 active API suppliers hold Drug Master Files for this ingredient.

FINE CHEMICALS CORP PTY LTDFLUPHENAZINE DECANOATE

DMF 60261985

TRIFARMA SPAFLUPHENAZINE DECANOATE

DMF 278112013

GLAND PHARMA LTDFLUPHENAZINE DECANOATE

DMF 338992019

MSN LIFE SCIENCES PRIVATE LTDFLUPHENAZINE DECANOATE USP

DMF 339852019

SWORDS LABORATORIES LTDInactiveFLUPHENAZINE DECANOATE

DMF 19921972

ER SQUIBB AND SONS INCInactiveFLUPHENAZINE DECANOATE INJ.

DMF 23741974

ER SQUIBB AND SONS INCInactiveFLUPHENAZINE DECANOATE AND FLUPHENAZINE ENANTHATE

DMF 40201981

NV ORGANONInactiveFLUPHENAZINE DECANOATE

DMF 64091986

LABOCHIMInactiveFLUPHENAZINE DECANOATE

DMF 65791986

FINE CHEMICALS CORP PTY LTDInactiveFLUPHENAZINE DECANOATE OIL(BMS)

DMF 160972002

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (1)

#001 — 25MG/ML

0 patents0 exclusivities▴

INJECTABLE;INJECTION | Approved: Oct 17, 2017

No patent or exclusivity listings for this strength.